RFK Announces Team-Wide Partnership with Esperion Therapeutics; Includes Primary Partnership for Brad Keselowski at the ’23 Daytona 500
Esperion Therapeutics has secured a multi-year partnership with RFK Racing, which will see its cholesterol-lowering treatments, NEXLIZET and NEXLETOL, showcased in the upcoming NASCAR season.
NEXLIZET will debut on Brad Keselowski's No. 6 Ford during the Daytona 500 on February 19, while NEXLETOL will be featured on Chris Buescher's No. 17 Ford throughout the season.
Esperion aims to raise brand awareness and educate consumers on cardiovascular health through this collaboration.
- Multi-year agreement with RFK Racing boosts visibility for NEXLIZET and NEXLETOL.
- Showcase at high-profile NASCAR events like the Daytona 500 potentially enhances brand recognition.
- Opportunity for community engagement and consumer education on cholesterol management.
- None.
NASCAR Champion Brad Keselowski to Run No. 6 NEXLIZET (bempedoic acid and ezetimibe) Ford in Famed Daytona 500
CONCORD, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- RFK Racing has announced that Esperion Therapeutics, a Michigan-based pharmaceutical company, has partnered with the team for a multi-year agreement pursuant to which Esperion will promote two cholesterol lowering treatments – NEXLIZET (bempedoic acid and ezetimibe) and NEXLETOL (bempedoic acid). NEXLIZET will be featured on Keselowski’s No. 6 Ford at this year’s Daytona Speedweeks, including the famed Daytona 500 on February 19. NEXLETOL will be featured throughout the season on Chris Buescher’s No. 17 Ford.
Headquartered in Ann Arbor, Michigan, Esperion discovers, develops, and commercializes innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by current treatment options.
“We’re thrilled to have Esperion, a company that is making waves in the pharmaceutical industry, on board with us,” said Steve Newmark, President of RFK Racing. “We look forward to working with Esperion to create engaging content around their two products in NEXLIZET and NEXLETOL and showcasing their debut on the No. 6 for the famed Daytona 500. We’re thankful to the team at Esperion and can’t wait to introduce them to the sport in a big way in 2023.”
In addition to the Daytona 500 (Feb. 19, 2:30 p.m. ET, FOX), Esperion will serve as a primary on the No. 6 Ford at the All-Star Race at North Wilkesboro Speedway (May 21, 8 p.m. ET, FS1) and RFK’s home track at Michigan (Aug. 6, 2:30 p.m. ET, USA).
The brand will serve as a primary on the No. 17 at Las Vegas (March 5, 3:30 p.m. ET, FOX), Martinsville Spring (April 16, 3 p.m. ET, FS1), and Martinsville Fall (Oct. 29, 2 p.m. ET, NBC).
“We’re excited to partner with RFK Racing to increase brand awareness, and this sponsorship provides ample opportunities for community engagement and education to their large and diverse consumer base to advance awareness about the benefits of lowering LDL cholesterol and improving cardiovascular health,” said Sheldon Koenig, Esperion’s President and CEO.
Keselowski enters his second season at RFK and 14th full season in the NASCAR Cup Series (NCS). With 35 Cup wins to his credit, he is set to make his 500th Cup start in 2023. Buescher, now in his fourth season back with RFK, embarks on his eighth full-time season of Cup competition.
At Daytona and Michigan combined, Keselowski has 19 combined top-10 efforts, including a win in the 2022 Duels where RFK swept the season-opening exhibition qualifying races. At the two-mile Michigan facility, he has top-10s in half of his all-time starts in his home state.
Coming off a victory in the historic Bristol Night Race, Buescher will carry the NEXLETOL banner at another short track in Martinsville, in addition to the race at Las Vegas.
The 2023 NASCAR season unofficially kicks off with the Clash at the Coliseum (8 p.m. ET, FOX) on Sunday, Feb. 5, in Los Angeles. Coverage of Daytona 500 week begins on Wednesday, Feb. 15, with full-field qualifying, followed by the Duels on Thursday, and a pair of practice sessions set to take place Friday and Saturday.
About Esperion
Esperion works hard to make our medicines easy to get, easy to take, and easy to have. We discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.
About RFK Racing
RFK Racing, in its 36th season in 2023, features an ownership lineup pairing one of the sport’s most iconic names, Jack Roush, along with NASCAR Champion, Brad Keselowski, and Fenway Sports Group owner John Henry. Roush initially founded the team in 1988 and it has since become one of the most successful racing operations in the world, propelling him to be the first NASCAR owner to amass three hundred wins and capturing eight championships, including back-to-back NASCAR Cup titles in 2003 and 2004. Keselowski, a former owner in the NASCAR Truck Series, brings to the team a championship mindset himself having won the 2012 NASCAR Cup Series Championship. In 2007, Roush partnered with Henry, who also owns Major League Baseball’s Boston Red Sox, English Premier League’s Liverpool F.C., and the NHL’s Pittsburgh Penguins, to form Roush Fenway Racing. Off the track, RFK is a leader and proven winner in NASCAR marketing solutions, having produced multiple award-winning social media, digital content and experiential marketing campaigns. Visit rfkracing.com, and follow the team on all social platforms @rfkracing.
Contact:
Esperion Corporate Communications
corporateteam@esperion.com
FAQ
What is Esperion Therapeutics' role in the NASCAR 2023 season?
When will NEXLIZET be featured on the race cars?
What events will Esperion's products be promoted at?
What is the main goal of Esperion's partnership with RFK Racing?
Who is driving the No. 6 car for RFK Racing?
